Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report. Dermatol Pract Concept 2024, 14 (4), e2024252. https://doi.org/10.5826/dpc.1404a252.